{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:20:52Z","timestamp":1790014852028,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/0973-1482.157340","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T10:04:01Z","timestamp":1521799441000},"page":"S60-S64","source":"Crossref","is-referenced-by-count":10,"title":["MiR-186 inhibits cell proliferation and invasion in human cutaneous malignant melanoma"],"prefix":"10.4103","volume":"14","author":[{"given":"Bei-bei","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-bin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20230619","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archdermatol.2009.379","article-title":"Trends in dermatology: Melanoma incidence","volume":"146","author":"Rigel","year":"2010","journal-title":"Arch Dermatol"},{"key":"R2-10-20230619","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3322\/caac.21224","article-title":"Recent developments in the medical and surgical treatment of melanoma","volume":"64","author":"Saranga-Perry","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"R3-10-20230619","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/sj.bjc.6605204","article-title":"Role of miRNAs in the progression of malignant melanoma","volume":"101","author":"Mueller","year":"2009","journal-title":"Br J Cancer"},{"key":"R4-10-20230619","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/carcin\/bgs205","article-title":"MicroRNA and cutaneous melanoma: From discovery to prognosis and therapy","volume":"33","author":"Segura","year":"2012","journal-title":"Carcinogenesis"},{"key":"R5-10-20230619","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/1471-2407-10-262","article-title":"High-throughput miRNA profiling of human melanoma blood samples","volume":"10","author":"Leidinger","year":"2010","journal-title":"BMC Cancer"},{"key":"R6-10-20230619","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1158\/0008-5472.CAN-12-2651","article-title":"miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation","volume":"73","author":"Cai","year":"2013","journal-title":"Cancer Res"},{"key":"R7-10-20230619","doi-asserted-by":"crossref","first-page":"8933","DOI":"10.1007\/s13277-014-2168-6","article-title":"MiR-186 targets ROCK1 to suppress the growth and metastasis of NSCLC cells","volume":"35","author":"Cui","year":"2014","journal-title":"Tumour Biol"},{"key":"R8-10-20230619","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/carcin\/bgt158","article-title":"PTTG1 promotes migration and invasion of human non-small cell lung cancer cells and is modulated by miR-186","volume":"34","author":"Li","year":"2013","journal-title":"Carcinogenesis"},{"key":"R9-10-20230619","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.7314\/APJCP.2014.15.10.4245","article-title":"miR-186 regulates glycolysis through Glut1 during the formation of cancer-associated fibroblasts","volume":"15","author":"Sun","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R10-10-20230619","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1007\/s00268-008-9833-0","article-title":"Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis","volume":"33","author":"Zhang","year":"2009","journal-title":"World J Surg"},{"key":"R11-10-20230619","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1158\/0008-5472.CAN-09-1891","article-title":"Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer","volume":"70","author":"Myatt","year":"2010","journal-title":"Cancer Res"},{"key":"R12-10-20230619","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbrc.2012.10.117","article-title":"MiR-186, miR-216b, miR-337-3p, and miR-760 cooperatively induce cellular senescence by targeting alpha subunit of protein kinase CKII in human colorectal cancer cells","volume":"429","author":"Kim","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-10-20230619","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1002\/hep.23939","article-title":"Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms","volume":"52","author":"Goeppert","year":"2010","journal-title":"Hepatology"},{"key":"R14-10-20230619","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1750-3639.2011.00523.x","article-title":"Genetic alterations in microRNAs in medulloblastomas","volume":"22","author":"Lv","year":"2012","journal-title":"Brain Pathol"},{"key":"R15-10-20230619","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1755-8794-4-79","article-title":"miRNA signature associated with outcome of gastric cancer patients following chemotherapy","volume":"4","author":"Kim","year":"2011","journal-title":"BMC Med Genomics"},{"key":"R16-10-20230619","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2407-14-82","article-title":"Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAs","volume":"14","author":"Erdmann","year":"2014","journal-title":"BMC Cancer"},{"key":"R17-10-20230619","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3892\/or.2014.2983","article-title":"miR-186, miR-3651 and miR-494: Potential biomarkers for oral squamous cell carcinoma extracted from whole blood","volume":"31","author":"Ries","year":"2014","journal-title":"Oncol Rep"},{"key":"R18-10-20230619","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/med.20215","article-title":"Circulating microRNAs: A novel class of biomarkers to diagnose and monitor human cancers","volume":"32","author":"Zen","year":"2012","journal-title":"Med Res Rev"},{"key":"R19-10-20230619","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.mehy.2011.08.017","article-title":"Towards an extension of the two-variable model of carcinogenesis through oncogenes and tumour suppressor genes","volume":"77","author":"Tourvas","year":"2011","journal-title":"Med Hypotheses"},{"key":"R20-10-20230619","doi-asserted-by":"crossref","first-page":"28274","DOI":"10.1074\/jbc.M802663200","article-title":"MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2x7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript","volume":"283","author":"Zhou","year":"2008","journal-title":"J Biol Chem"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814001-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:27:53Z","timestamp":1786724873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814001-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":20,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.157340","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}